Controversial and divisive, but Kennedy’s expertise is intended for one thing: change.

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry

At this time of year, we like to recognize the people and companies that have helped drive innovation and success – but we need your help.

What’s going on in UK life sciences? How the government is offering support to the sector and investing in talent.

An HBV gene editing clinical trial has been approved in Moldova, but the challenges go beyond science and industry.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

The increasing focus on sustainability in the pharmaceutical industry amongst CDMOs reveals the key strategies and initiatives being undertaken.

EFPIA signs joint declaration championing open trade in the EU.